Why is Makers Labs. falling/rising?

Persistent Underperformance Against Benchmarks

Makers Laboratories has been struggling to keep pace with the broader market indices, as evidenced by its returns relative to the Sensex. Over the past week, the stock has declined by 5.56%, while the Sensex recorded a modest gain of 0.10%. This divergence extends over longer periods, with the stock down 9.38% in the last month compared to the Sensex’s 1.11% rise. Year-to-date figures reveal a stark contrast: Makers Labs has fallen 33.86%, whereas the Sensex has appreciated by 9.70%. Even over a five-year horizon, the stock has declined by 20.38%, while the Sensex surged by 94.16%. These figures highlight a sustained period of underperformance that has weighed heavily on investor confidence.

Technical Indicators Signal Weak Momentum

The technical landscape for Makers Laboratories is notably bearish. The stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This positioning typically signals a lack of upward momentum and suggests that the stock is in a downtrend. Additionally, the weighted average price indicates that a greater volume of shares was traded closer to the day’s low, reflecting selling pressure throughout the trading session.

Price Action and Volatility on 27-Nov

On the day in question, Makers Labs touched an intraday high of ₹128.65, representing a 2.84% increase from the previous close, but this was overshadowed by a sharp fall to an intraday low of ₹118.40, down 5.36%. The stock’s closing price was just 2.17% above its 52-week low of ₹117.15, underscoring its proximity to multi-year lows. The stock has also recorded losses over the last two consecutive days, with a cumulative decline of 5.89% during this period, further emphasising the negative sentiment prevailing among investors.

Declining Investor Participation and Liquidity Considerations

Investor engagement appears to be waning, as indicated by a sharp drop in delivery volume. On 26 Nov, the delivery volume was recorded at 456 shares, marking an 80.23% decrease compared to the five-day average delivery volume. This decline in investor participation often signals reduced conviction in the stock’s near-term prospects. Despite this, the stock remains sufficiently liquid for trading, with the average traded value supporting reasonable trade sizes, although the lack of strong buying interest is a concern.

Sector and Market Context

While the broader market and sector indices have shown resilience, Makers Laboratories has lagged behind, underperforming its sector by 4.16% on the day. This relative weakness suggests company-specific challenges or investor concerns that are not reflected in the wider pharmaceutical or healthcare sectors. The absence of positive catalysts or news further compounds the negative sentiment, leaving the stock vulnerable to continued selling pressure.

Outlook and Investor Takeaway

The current data paints a challenging picture for Makers Laboratories. The stock’s proximity to its 52-week low, combined with persistent underperformance against benchmarks and declining investor participation, suggests that caution is warranted. The technical indicators reinforce the bearish outlook, with the stock trading below all major moving averages and experiencing heavier volume near its lows. Investors should closely monitor any changes in trading volumes or price action that might signal a reversal, but for now, the prevailing trend remains downward.

In summary, the decline in Makers Laboratories’ share price on 27-Nov is a reflection of sustained negative momentum, weak investor interest, and underwhelming relative performance compared to the broader market and sector peers. Until there is a clear shift in these factors, the stock is likely to remain under pressure.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →